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Enhancement of the physicochemical properties of
[Pt(dien)(nucleobase)]2+ for HIVNCp7 targeting†
S. D. Tsotsoros,a P. B. Lutz,bc A. G. Daniel,a E. J. Peterson,ad R. E. F. de Paiva,a E. Rivera,a
Y. Qu,a C. A. Bayse*c and N. P. Farrell*ad
Physicochemical properties of coordination compounds can be exploited for molecular recognition of
biomolecules. The inherent p–p stacking properties of [Pt(chelate)(N-donor)]2+ ([PtN4]) complexes were
modulated by systematic variation of the chelate (diethylenetriamine and substituted derivatives) and
N-donor (nucleobase or nucleoside) in the formally substitution-inert PtN4 coordination sphere.
Approaches to target the HIV nucleocapsid protein HIVNCp7 are summarized building on (i) assessment
of stacking interactions with simple tryptophan or tryptophan derivatives to (ii) the tryptophan-containing
C-terminal zinc finger and (iii) to the full two-zinc finger peptide and its interactions with RNA and DNA.
The xanthosine nucleoside was identified as having significantly enhanced stacking capability over
guanosine. Correlation of the LUMO energies of the modified nucleobases with the DFT p-stacking
energies shows that frontier orbital energies of the individual monomers can be used as a first estimate
of the p-stacking strength to Trp. Cellular accumulation studies showed no significant correlation with
lipophilicity of the compounds, but all compounds had very low cytotoxicity suggesting the potential for
antiviral selectivity. The conceptual similarities between nucleobase alkylation and platination validates
the design of formally substitution-inert coordination complexes as weak Lewis acid electrophiles for
selective peptide targeting.
Introduction
Design of dened coordination compounds in medicine uses
the inherent physical and chemical properties of the coordi-
nation compound, or metal ion, to achieve specic effects.
Properties such as paramagnetism and/or radioactive emission
of Gd and Tc, respectively, coupled with appropriate chemical
structure produce useful imaging agents whose biological
properties can be further modied by suitable chemical design.1
Development of platinum-based anticancer agents has been
predicated on the necessity for Pt–DNA bond formation where
the conformational distortion subsequently produced by
binding of the square planar coordination sphere eventually
disrupts nucleic acid function. In the latter case, challenges to
the orthodoxy of the necessity for Pt–DNA bond formation
has come from the recent demonstrations that formally
substitution-inert polynuclear platinum complexes can display
signicant in vitro and in vivo anti-tumor activity equivalent to
cisplatin itself.2 Metallohelicates are a further example of use of
“non-covalent” recognition of discrete DNA sequences with
consequences for protein recognition.3 Use of formally substi-
tution-inert compounds is attractive as it may allow greater
control of the biologically relevant reactions as well as
improving pharmacokinetics through elimination of wasteful
non-specic biomolecule covalent bond formation.
A further example of formally substitution-inert compounds
for biological applications is in the use of PtN4 nucleobase
compounds to act as Lewis acid electrophiles targeting zinc
ngers (ZF), and especially the HIV NCp7 nucleocapsid protein
(NCp7).4,5 NCp7 is a small basic zinc nger protein containing
two Cys2HisCys zinc coordination motifs and is involved in
nearly all stages of the viral life cycle.6,7 NCp7 is of considerable
interest as a drug target because it is highly conserved among
retroviruses and is intolerant to mutation.6,8 A critical feature of
NCp7–DNA/RNA recognition is the stacking of aromatic resi-
dues (Trp, Phe) with purine and pyrimidine bases (guanine,
cytosine) of the oligonucleotide.9–11 Nucleobase metallation,
analogous to protonation or alkylation, enhances their p–p
stacking to aromatic amino acids.12,13 Metallation of 9-EtGua in
[M(dien)(9-EtGua)]n+ (M¼ Pt, Pd n¼ 2; M¼ Au, n¼ 3) produces
a 2–5-fold increase in the association constant with N-acetyl-
tryptophan (N-AcTrp) compared to the free nucleobase.12–15 The
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general enhancement also extends to pyrimidines such as
1-mecytosine and even heterocyclic aromatic ligands based on
pyridine and thiazole.12,14,16 The application in this manner of
an intrinsic biophysical property of a complex such as
[Pt(dien)(9-EtGua)]2+ – the p–p stacking of the platinated
nucleobase with a tryptophan moiety – is therefore a recogni-
tion motif for binding to an appropriate peptide such as NCp7
capable of modulation to inhibit the “intrinsic” nucleic acid
interaction. Measured association constants to the C-terminal
NCp7 for [Pt(dien)(9-EtGua)]2+ and [Pt(dien)(50-GMP)] (7.5 and
12.4  103 M1 respectively) compared to that observed for
a representative hexanucleotide d(TACGCC) where Ka¼ 60.03
103 M1.4,17
A second advantage of formally substitution-inert complexes
is to infer selectivity toward eventual Pt-bond forming reactions
upon target recognition. An inherent problem for any applica-
tion of zinc nger targeting is the variety of relevant structural
motifs and functions.18 Analysis of the protein packing and
electrostatic screening in a wide range of zinc ngers led to
the attractive postulate that weak organic electrophiles were
capable/likely candidates for selective attack on the highly
nucleophilic zinc-cysteinates of NCp7.19,20 The concept has been
applied for targeting both the HIVNCp7 and also the DNA
binding domain of the estrogen receptor (ERDBD).20,21 For
coordination compounds the PtN4 chemotype (in this case
{PtN3(nucleobase)}) is the Lewis acid equivalent of a weak
“organic” electrophile, signicantly less reactive than the cor-
responding MClN3 unit with a substitution-labile M–Cl bond.
In agreement, substitution of the nucleobase in [Pt(dien)(9-
EtGua)]2+ by the sulfur nucleophile N-AcCys is signicantly
slower than for the [PtCl(dien)]+ species.22 Incorporation of
a Trp into a short 4-amino acid sequence (GAWG versus GAMC)
increases the rate of reaction, and perhaps specicity, with
[Pt(dien)(9-EtGua)]2+.22 Theoretical calculations on the
[Pt(dien)(9-EtGua)]2+–GWMG/GAMG interactions show that the
formation of the GWMG species is roughly 5 kcal mol1 more
stable than for the GAMG species (9.3 and 3.9 kcal mol1),
due to the additional stacking interaction.
The [Pt(dien)(nucleobase)]n+ coordination sphere is a useful
template for systematic studies as it allows for modication on
both the dien ligand and nucleobase to enhance stacking
interactions and reactivity as well as the properties of cellular
accumulation and cytotoxicity. In this contribution we examine
the modulation of non-covalent interactions on the C-terminal
zinc nger (ZF2) and the ‘full” 2-nger peptide (NCp7) and show
that ZF2 studies are a good prognosticator for the reactivity of
the full peptide with signicant enhancement of stacking
interactions using xanthosine over guanosine as nucleoside.
The complexes are weak inhibitors of the NCp7–DNA/RNA
interaction and the inhibition correlates with the observed
stacking interaction. We examine the origins of the enhanced
effects of xanthosine over guanosine complexes and show that
computational approaches are useful in analysis of the strength
of the p-stacking interaction as a quick estimation of the ability
to inhibit NCp7 and can be used to identify secondary interac-
tions in the binding site to aid in design of effective inhibitors.
The studies conrm the potential for modulation of the
physicochemical properties of platinum-based compounds to
enhance inhibition of a fundamental biological property – the
NCp7–RNA(DNA) annealing.
Results and discussion
Characterization and chemical properties of Pt–purine
compounds
The target compounds were designed to rstly examine the
effect of the planar ligand on the stacking interaction using
modied purines and nucleosides. Secondly, steric effects and
lipophilicity were incorporated into the “carrier” portion of the
molecule by varying the nature of the dien ligand. The struc-
tures are shown in Fig. 1. Platination at the purine N7 in all
cases is conrmed by the typical downeld shis of the H(8)
protons (see ESI†). Xanthine itself exists in tautomeric equilib-
rium between the keto and enol forms with consequently
a potential array of possible binding sites. The xanthine deriv-
ative itself gave multiple H(8) peaks indicative of linkage
isomers and was not considered further. The addition of methyl
groups to the dien ligand induces considerable steric hindrance
about the platinum–nucleobase bond, as observed in the
1H NMR spectra of 1c and 1d. In both cases the H8 signal of the
9-EtGua splits into a doublet due to restricted rotation.
Temperature dependence studies of the H8 signal reveal
a signicant difference between the N,N0-Me2dien compound
Fig. 1 General structure for [Pt(dien)L]2+ compounds, where the dien
can be methylated N–Me, N,N0-dimethyl or N,N0-N,N0-tetramethyl
and L is a nucleobase or nucleoside, as shown. Structure of the
HIVNCp7 nucleocapsid protein showing the two zinc fingers (A). The
red dashed line shows the C-terminal finger used in our studies. On
right is the SL2RNA sequence used (B).
1270 | Chem. Sci., 2017, 8, 1269–1281 This journal is © The Royal Society of Chemistry 2017
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and the N,N0-Me4dien compound (Fig. 2). For the N,N0-Me2dien
ligand the doublet coalesces to a broad peak at 35 C and then
begins to sharpen into a new doublet, with signicantly less
separation between the peaks. In contrast, little change is observed
for the N,N0-Me4dien ligand, even up to 70 C – implying little
interconversion.
The 195Pt NMR spectra of both the N,N0-Me4dien and
N,N0-Me2dien compounds also show broad signals in agreement
with the 1H NMR spectra, Fig. S2.† These peaks show some
coalescence but further broaden with increased temperature.
The 1H NMR spectra of the xanthosine derivatives also conrm
the steric hindrance – in this case the N,N0-Me2dien compound
is a broad singlet whereas the more sterically demanding
N,N0-Me4dien compound shows two clear singlets at 8.97 and
9.00 ppm. Their corresponding 195Pt NMR spectra again showed
broad signals consistent with the presence of rotamers.
The energies of the rotation barrier, Ebarrier, were calculated
following literature methods.23 There is a >2 kcal mol1 differ-
ence between Ebarrier for the two compounds, 15.90 and
17.92 kcal mol1 for N,N0-Me2dien and N,N0-Me4dien respec-
tively. The energy difference highlights the signicant steric
hindrance created by the methyl groups. In the case of the
N,N0-Me4dien ligand, DFT calculations gave two limiting struc-
tures (Scheme 1). In structure I, the 9-EtGua forms a close
contact within hydrogen-bonding distances between H(8) and
the N,N0-Me4dien ligand (3.06 A˚). The C(6)]O atom then has
a similar close contact (2.64 A˚) to the same NMe2 group of the
chelate. The alternative geometry, essentially resulting from
rotation of the purine around the platinum square plane,
results in the same contacts. Based on the model, structure 1
corresponds to the upeld peak and structure 2 corresponds to
the downeld peak of the [Pt(N,N0-Me4dien)(9-EtGua)]
2+.
Biological properties
The modular nature of the zinc nger template lends itself to
a systematic targeting approach through studying rstly the
fundamental stacking interactions with the simple tryptophan
or N-AcTrp followed by extension to the C-terminal nger
(containing the critical Trp ligand) and then the full zinc nger
protein itself where the stacking interaction is incorporated
into the protein and steric effects can be examined. Finally, the
effect of the complexes on the NCp7–nucleic acid interaction
can be assayed. Cellular properties and selectivity may also be
examined to obtain insight into possible selectivity as it is
important to understand the biological properties of the
platinum–nucleobases with respect to cellular accumulation
and cytotoxicity.
Binding affinity to tryptophan and zinc ngers. The
calculated Ka values are reported for the association of platinum–
nucleobase complexes with N-AcTrp and the C-terminal ZF2 of
HIV1 NCp7 (Table 1). Two trends are apparent. The addition of
the sugar moiety on guanosine (Guo) and xanthosine (Xan)
enhances the interaction with tryptophan slightly over the
“parent” 9-EtGua compound. The most notable trend, clearly, is
that for Xan the binding to the free NAc-Trp and the C-terminal
nger is signicantly increased in comparison to the Guo analog.
The inosine compound has the weakest interactions of all
compounds studied and is also the only example where binding to
the C-terminal nger is slightly less effective than for the simple
amino acid itself.
Interactions with the “full” NCp7 peptide. The uorescence
spectra of the full NCp7 peptide in presence of increasing
concentrations of [Pt(dien)(9-EtGua)]2+ is shown in Fig. 3A. The
calculated association constant is Ka ¼ 2.0  104 M1. The CD
spectrum and especially the maintenance of the positive band
centered at 210–220 nm shows that there is no major disruption
of the peptide in the presence of the compound and the zinc
nger tertiary structure is maintained (Fig. 3B).24,25 Values for
the Xan and Guo derivatives are 4.7 and 1.4  104 M1 respec-
tively, again showing the enhancement of association with
xanthosine. These values are not signicantly different from
those of the C-terminal nger reecting the fact that the Trp
residue resides on the C-terminal nger but do at one level
conrm that studies on the C-terminal nger alone, easier to
prepare and by denition somewhat cheaper, are a good
approximation to that for the full Zn nger in this context.
Modelling and docking studies. The advantage and
increased association constant of a nucleoside (guanosine) over
a purine (9-EtGua) in going from the simple amino acid trypto-
phan to the C-terminal peptidemay be due to additional H-bond
contributions from the sugar. The carbohydrate–aromatic ring is
a recognized important molecular recognition motif.26 This
interaction has been observed in the NMR solution structure of
Fig. 2 Temperature dependence of the 1H NMR splitting of the H8
signal for [Pt(N,N0-Me4dien)(9-EtGua)]
2+ (A) and [Pt(N,N0-Me2dien)(9-
EtGua)]2+ (B). The small peak in (B) at high Tmay be due to formation of
a minor new species with increasing T.
Scheme 1
This journal is © The Royal Society of Chemistry 2017 Chem. Sci., 2017, 8, 1269–1281 | 1271
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d(50-TACGCC-30) adducted to the C-terminal sequence used
here.17 Further, investigation of cTAR DNA-NC(11–55) protein
contacts indicates a signicant role for hydrophobic interactions
involving nucleobases and deoxyribose sugars with C10 and C20
of the sugar moieties in contact with the aromatic side chains of
Phe16 and Trp37.27 Docking calculations for the free nucleo-
bases (guanine and xanthine) in comparison with the corre-
spondent nucleosides conrms this trend of higher affinity
between the C-terminal nger and purine nucleosides with
sugar-containing species and supports the potential for
hydrogen bond network enhancement on the association
constant (Fig. S1 and Table S1†). The hydrogen-bonding network
between the nucleosides and the target protein is pretty much
the same for both Gua and Xan. There is an important interac-
tion between the sugar CH2OH and Gly35's amide group. The
endocyclic oxygen of furanose ring and the NH of the indole ring
are also involved in a hydrogen bond. Aminor interaction can be
observed between Glu42 and one of the OH groups found in the
sugar structure.
Computational studies. Computational and docking studies
have been used as predictive tools for small molecule design to
inhibit NCp7.28,29 A combination of electrostatic, hydrophobic,
solvation, charge-transfer, induction, and dispersion interactions
accounts for the three-dimensional arrangements observed in
biochemical recognition processes mediated through p-stacking
interactions, such as the interaction of purine and pyrimidine
rings with aromatic amino-acid residues such as tryptophan.30–33
We have previously used the relative energy difference between
the frontier orbitals of isolated molecules as a predictive tool for
the strength of the p-stacking interaction of the nucleobase/
tryptophan pair.13 The analysis correlated well with experimental
association constants, measured by uorescence spectroscopy, of
metallated (Pt, Pd) and methylated nucleobases with tryptophan
in comparison to free nucleobases.13
To analyze the trends in association constants from
Table 1, we performed DFT calculations with empirical
dispersion corrections to investigate the enhancement of the
Gua(Xan)–Trp interaction using “small models” of metalated
MeGua and Xan p-stacked with methylindole (MeInd) as
a model for Trp. The p-stacking energy, LUMO energies, and
charge transfer were examined in order to determine whether
the modied Gua with the lowest LUMO energies have the
largest charge transfer and the strongest p-stacking interac-
tions. Secondly, we examined a “large model” using the hybrid
ONIOM method to determine the effects of p-stacking and
hydrogen-bonding within a larger fragment of the C-terminal
zinc nger of NCp7.
Table 1 Experimental association constants for [Pt(R-dien)L]2+ (PtN4) complexes with N-AcTrp (black) and the C-terminal ZF2 of HIV1NCp7
(parentheses). Figures for the full NCp7 peptide are in (bold parentheses)
L
Ka (103) M1
[Pt(dien)L]2+ [Pt(N-Medien)L]2+ [Pt(N,N0-Me2dien)L]
2+ [Pt(N,N0-Me4dien)L]
2+
7-MeGua 9.01  0.09 — — —
(10.42  0.29) — — —
Ino 5.63  0.3 — — —
(3.20  0.29) — — —
9-EtGua 6.88  0.36 13.52  0.48 7.40  0.93 11.78  1.02
(13.10  0.94) (14.70  1.60) (12.02  0.37) (18.30  0.34)
(20  0.08)
Guo 13.10  1.29 12.78  0.22 6.84  0.67 15.19  1.21
(15.80  2.83) (12.11  1.13) (11.37  2.01) (9.16  1.46)
(14  0.05)
Xan 16.13  1.10 11.56  0.33 11.74  0.53 (11.30  0.36)
(46.64  0.28) (60.22  2.18) (35.80  0.76) (48.67  0.29)
(46.91  0.06) —
Fig. 3 (A) Fluorescence quenching of NCp7 in presence of increasing
amounts of [Pt(dien)(9-EtGua)]2+ (B) circular dichroism spectrum of
“full” NCp7 zinc finger peptide in presence of [Pt(dien)(9-EtGua)]2+.
1272 | Chem. Sci., 2017, 8, 1269–1281 This journal is © The Royal Society of Chemistry 2017
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Small p–p stacked structures
Small models of thep-stacking interaction betweenMeGua andN-
methylindole (MeInd), as a model for Trp, were optimized in the
same orientation (A) as found in the NMR solution structure of the
NCp7 nucleocapsid complexed with the DNA primer binding site
(PDB 2EXF).34 The interaction energies forp-stacking of the dimers
MeInd-[Pt(NH3)3(9Me-Gua)]
2+, MeInd-[Pt(NH3)3(7-Me-Gua)]
2+ and
MeInd-[Pt(NH3)3(Xan)]
2+ were compared to experimental equilib-
rium constants for interaction of Trp with the analogous
[Pt(dien)(nucleobase)]2+ complexes (Table 1).12,13 The DFT/B97-D
optimized geometries of the individual square-planar [Pt(NH3)3
(MeGua)]2+ (where MeGua refers to 7/9-MeGua) complexes and
their LUMO energies were comparable to previous studies
(Table 2).13 The numbering scheme and optimized structures for
the [Pt(NH3)3(purine)]
2+ (purine ¼ 9-EtGua, 7-MeGua and
xanthine) are given in Fig. S3.†
In the optimized p-stacked structures, Gua/Xan are not
directly eclipsed over MeInd, consistent with general trends in
p-stacking interactions (Fig. 4).35 The inter-ring distances for
MeInd-9-MeGua (3.2–3.3 A˚) were slightly smaller than those
found in the crystal structures of Ind–Gua stacked pairs
(3.4–3.5 A˚).36 Metalation resulted in p-stacking interactions in
which the C2 end of the purine is closer toMeInd than the N7 end
(i.e., 3.2 and 3.5 A˚, respectively, for MeInd-[Pt(NH3)3(9-MeGua)]
2+).
The tilt angles are similar to that found by Rutledge et al. for an
adenine–histidine dimer (10) and increase as MeInd-MeGua <
MeInd-[Pt(NH3)3(9-MeGua)]
2+ < MeInd-[Pt(NH3)3Xan]
2+.37 An
electrostatic interaction between the MeInd p cloud and
a hydrogen causes one ammine ligand of the metalated base to
extend down into the space between the p-stack, but this inter-
action is likely to compete with hydrogen bonding with the
aqueous solvent. Metalation enhanced the p-stacking energy by
13–18 kcal mol1 relative to uncomplexed 9-MeGua, consistent
with the enhancement of the donor–acceptor interaction through
stabilization of the metal-complexed nucleobase LUMO (Fig. 5).
Charge decomposition analysis shows that the net electron
donation from MeInd to Gua increases by 0.1e upon metallation,
comparable to that found for ap-stacked dimer of benzene within
a trinuclear Cu(I) triiodide cluster (0.14e).38
Larger models
Although the analysis of the donor–acceptor HOMO–LUMO gap
is useful when one deals with the simple p-stacked structures,
factors such as hydrogen bonding and steric effects also
contribute to binding to the recognition site. For example,
molecular dynamics studies of NCp7 bound to DNA and RNA
show hydrogen bonding interactions involving Gua and resi-
dues G35, W37 and M46.28 The effect of the surrounding
residues on the Trp–Gua interaction was explored using the
ONIOM(B97-D:PM6) hybrid quantum-mechanical-semiempirical
method on a “large model” of the C-terminal NCp7 zinc nger
truncated to residues 32 to 40 and 44 to 49 of the NMR structure
of HIV-1 NCp7 complexed with DNA() primer binding site
(PDB 2EXF), (Fig. 6).34 Lysines 34 and 38 were further truncated to
Ala and the side chain of K47 was replaced by an ethyl group. The
DFT region, indicated in Fig. 6 with a ball-and-stick representa-
tion, was allowed to optimize freely. The remainder of the model
was treated with the PM6 semiempirical method and constrained
to the NMR structure.
Interactions between the protein and DNA phosphate back-
bone limit Gua to the native conformation A observed in the
NMR structure (Fig. 6). Without the phosphate backbone, Gua
derivatives could theoretically p-stack with Trp in different
orientations. Geometry optimizations of the “large model” were
performed with Gua in the native A and three additional
conformations (B–D in Fig. S2†). The orientation of MeGua
affects both the nature of the p-stacking interaction and the
number and type of hydrogen bonding interactions with the
protein. In A, p-stacking is supplemented by hydrogen bonding
between the Gua carbonyl oxygen and the W37 NH on the
backbone as expected from the NMR structure. In the ONIOM
model, the Q45 and R32 side chains interact with Gua instead of
the absent phosphate backbone. The relative energies of A–D are
related to the number and strength of their H-bonding interac-
tions (Fig. S4, Table S2†). Structure B was the most stable
conformation followed by the native structure A (+6.2 kcalmol1),
D (11.7 kcal mol1) and C (+15.7 kcal mol1). The higher relative
energies for C and D can be attributed in part to a smaller
number of hydrogen-bonding interactions to the protein frag-
ment. To quantify the effect of the hydrogen bonding, natural
bond orbital donor–acceptor energies (DEd/a) were calculated
for key hydrogen bonding interactions inA–D (Table S2†). A small
model ofMeInd-[Pt(NH3)3(9-MeGua)]
2+ in orientation Bwasmore
stable that A, suggesting that B is preferred due to the more
favorable electrostatics of the hydrogen bonding interactions in
that orientation.
Table 2 DFT optimized results for small p-stacked dimers. The LUMO and LUMO+1 energies in eV for all Gua analogues. The p-interaction
energy was calculated as the difference of the dimer and monomer DFT energy. Electron donation from donor to acceptor d and back donation
b (e). The experimental Ka values are for 9-EtGua, (Pt(dien)L)
2+ L ¼ 7-MeGua, 9-EtGua, Xan with NAc-Trp (this paper).13,35 For all computational
studies Xan was N7-bound xanthine
Small structures
LUMO Gua
(eV)
LUMO+1
Gua (eV)
DE
(kcal mol1) d(e) b(e) d–b(e)
Ka
(103) M1
MeInd-MeGua 0.87 0.82 13.69 0.048 0.052 0.004 3.50
MeInd-(NH3)3Pt(9-MeGua)
2+ 9.36 8.25 26.70 0.124 0.027 0.097 6.88
MeInd-(NH3)3Pt(7-MeGua)
2+ 9.52 8.12 31.34 9.01
MeInd-(NH3)3Pt(Xan)
2+ 9.92 8.97 30.83 0.147 0.027 0.121 16.13
Struct. B MeInd-(NH3)3Pt(9-MeGua)
2+ 9.36 8.25 27.57 0.140 0.023 0.117
This journal is © The Royal Society of Chemistry 2017 Chem. Sci., 2017, 8, 1269–1281 | 1273
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Fig. 4 DFT B97-D optimized p-stacked structures of the small models of MeInd with Gua derivatives and Xan. The distances are labeled in A˚.
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Platinated Gua and Xan were modeled in orientations A and
B to determine the effect of hydrogen-bonding and LUMO
stabilization on the ability of the Pt(NH3)3 fragment to t into
the binding site in a different conformation (Fig. 7 and Table 3).
C and D were omitted because they could not accept the
Pt(NH3)3 fragment due to steric constraints. The interaction
energy of the metalated Gua/Xan with the NCp7 models was
calculated relative to the MeGua bound model by eqn (1):
NCp7–MeGua + M(NH3)3MeGua/Xan
2+/
NCp7–M(NH3)3MeGua/Xan
2+ + MeGua (1)
[Pt(NH3)3(9-MeGua)]
2+ complexed to the large model in
orientation A was more strongly interacting than free 9-MeGua
by 35.2 kcal mol1. The p-stacking interactions shi slightly
to accommodate steric and hydrogen-bonding interactions
resulting from platination but, similar to the small models, the
purine and indole rings have a 9.5 tilt angle Pt(NH3)3 fragment.
In both structures, hydrogen bonding between the ammine
ligands and the Gua C]O inuences the interactions with the
protein. In A, the interaction of the latter with the peptide
backbone at W37 is weakened, but in B, the amide side chain of
Gln45 ips so that its C]O can interact with the Pt ammine
Fig. 5 Correlation of the p-stacking interaction with the nucleobase
LUMO energy (eV).
Fig. 6 ONIOM(B97-D:PM6)-optimized structure of the truncated model of NCp7 bound with 9-MeGua in the native conformation A. (a) The
truncated NCP7 finger 2 used in calculations, blue residues were used without truncation, the red residues were truncated to Ala, K47 was
truncated to a modified Ala with ethyl group and black residues were eliminated. (b) Structure A. The truncated optimized model of NCp7
complexed with 9-MeGua with the p interaction shown only. 9-MeGua is shown in yellow. (c) ONIOM optimized native structure. Ball and stick
representations correspond to the QM region, stick representation correspond to the SE region. (d) The hydrogen bonding interactions structure
A. Bond lengths are given in A˚.
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ligands. The lower stability of B (+4.3 kcal mol1) can be
attributed to the electrostatic interactions between the Pt(NH3)3
fragment and the Arg32 side chain. In A, Pt(NH3)3 forms a close
interaction with the divalent sulfur of M46 (2.26 A˚; DEd/a ¼
13.6 kcal mol1), which agrees with the NMR structure of the
C-terminal NCp7 peptide complexed with the {Pt(dien)-
d(TACGCC)} in which the Pt(dien) fragment is in close proximity
to themethionine sulfur.17 This result both conrms the validity
of the large model and emphasizes the importance of the non-
zinc-bonded residues in dictating the overall reaction.
The largemodels of NCp7-[Pt(NH3)3(Xan)]
2+ binding assumed
an orientation similar to A to allow for the ammine–Met46
interaction and the more favorable electrostatic interaction
between Arg32 and the C2 carbonyl. As a result, the interaction of
metallated Xan was 10 kcal mol1 more favorable that of
[Pt(NH3)3(9-MeGua)]
2+. Hydrogen-bonding interactions were
similar to the 9-MeGua analogue, except for a shi in stacking to
allow for the C6 carbonyl to interact with backbone amides of
W37 and M46 (Fig. 7).
Summary and correlation. The correlation of the LUMO
energies of the modied nucleobases in our small model study
with the Kp values and the DFT p-stacking energies shows that
frontier orbital energies of the individual monomers can be used
as a rst estimate of thep-stacking strength to Trp. Metalation was
found to enhance the p-stacking interaction as predicted by the
lowering of the LUMO energy to strengthen a donor–acceptor
interaction. The large model ONIOM(B97-D:PM6) interaction
energies correlate with the available experimental Ka values, sup-
porting the use of DFT modeling for initial screening of potential
targets to predict favorable p-stacking interactions through the
nucleobase LUMO energy and capable of giving a quick estimation
of p-stacking energy and the ability to inhibit NCp7 (Fig. 8). Large
models further show the hydrogen bonding interactions with the
binding site which can be targeted through molecular design.
Fig. 7 (a) ONIOM(B97-D/PM6)-optimized structure of the large NCp7 model with [Pt(NH3)3(9MeGua)]
2+ in native conformation A. Hydrogen
bonding interactions and p-stacking conformations for complexes of the large model with [Pt(NH3)3(9-MeGua)]
2+ (A (b) and B (c)) and
[Pt(NH3)3(Xan)]
2+ (d).
1276 | Chem. Sci., 2017, 8, 1269–1281 This journal is © The Royal Society of Chemistry 2017
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Inhibition of the NCp7–RNA(DNA) interaction
Given the trends in the association constants and the
good correlations with computational studies the next question to
ask is how does the stacking interaction affect the peptide–nucleic
acid interaction? As part of the viral packaging process, NCp7
binds to viral RNA, which is comprised of four stem loops (SL).
SL2 and SL3 bind strongly to NCp7 and with similar affinity
compared to SL1 and SL4.39,40 The ability of the compounds to
inhibit or dissociate the complex between NCp7 and SL2 was
evaluated by electromobility gel shi assays (EMSAs).41 As previ-
ously reported, hairpin SL-2 RNA interacts with the zinc-knuckle
motifs present in NCp7.42 The interaction of NCp7 with 32P-SL2 is
apparent in Fig. 9A–D as a shi from the faster migrating species
(free RNA, lane 1) to the slower migrating species (bound RNA,
lane 2). Both [Pt(dien)(9-EtGua)]2+ and [Pt(dien)(xanthosine)]2+
disrupt the interaction of SL-2 with NCp7. The addition order of
SL-2 or inhibitors to the reaction mixture with NCp7 did not alter
their capacity to disrupt the NCp7–SL2 complex. [Pt(dien)(Xan)]2+
inhibits the complex more effectively when added to preformed
NCp7–SL2 (Fig. 9C and D), and requires 4 times less concentra-
tion than [Pt(dien)(9-EtGua)]2+ (Fig. 9A and B).
The [Pt(dien)(Xan)]2+ reactions with NCp7 and SL2 showed
an additional slower migrating band on the gel (Fig. 9C and D).
Control experiments identied this species as inhibitor – RNA
aggregates, which appear to form at the expense of the pool of
free SL2. The study of model DNA quadruplexes formed exclu-
sively by guanine and xanthine showed, for the latter case, that
a major interaction responsible for maintaining the helical
structure was p-stacking.43 Thus, an inevitable consequence of
enhancing stacking is also to enhance RNA affinity. Yet, the
affinity of [Pt(dien)(Xan)]2 interactions for DNA or RNA is ex-
pected to be relatively low.16 Specic NCp7–SL2 binding would
likely out-compete this type of interaction, particularly once
the complex is formed. Therefore, it is hypothesized that
[Pt(dien)(Xan)]2+ undergoes two concurrent binding events: (1)
specic (1 : 1) high affinity binding with NCp7 and (2)
nonspecic and low affinity binding with RNA.
Cellular accumulation and cytotoxicity
The end-product of any biophysical study is to achieve suitable
cellular activation. Two parameters which dictate anti-viral
specicity are cellular accumulation and cytotoxicity. In the case
Table 3 ONIOM(B97-D:PM6) results for platinated MeGua and Xan bound to NCp7 model. NPA charges of hydrogen bond donors (qD) and
acceptors (qA), distances and WBI values for the hydrogen bonded pairs
Donor qD (e) Acceptor qA (e) d, A˚ DEd/a (kcal mol
1) WBI
NCp7-[Pt(NH3)3(9-MeGua)]
2+ native A
MeGau C]O 0.712 W37 BB N–H 0.407 2.08 6.44 0.025
G35 BB C]O 0.779 MeGua N1–H 0.462 1.88 12.26 0.044
G35 BB C]O 0.779 MeGau NH2–Ha 0.432 1.93 10.47 0.039
Q45 SC C]O 0.745 MeGau NH2–Hb 0.435 1.92 12.32 0.048
M46 SC S 0.065 Pt–NH3 N–H 0.435 2.21 13.63 0.084
MeGau C]O 0.712 M46 BB N–H 0.400 2.39 1.25 0.008
MeGau C]O 0.712 M46 SC C–H 0.211 2.20 1.59 0.005
MeGau C]O 0.712 Pt–NH3 N–H 0.444 2.46 0.58 0.005
NCp7-[Pt(NH3)3(9-MeGua)]
2+ B
MeGau N3 0.627 M46 SC N–H 0.411 2.26 4.63 0.018
K34 BB C]O 0.736 MeGau NH2–Ha 0.441 1.88 14.41 0.050
K34 BB C]O 0.736 MeGua N1–H 0.461 2.32 2.45 0.012
G35 BB C]O 0.694 MeGau NH2–Hb 0.436 2.47 0.94 0.004
Q45 SC C]O 0.750 Pt–NH3 N–H 0.466 1.84 17.69 0.053
MeGau C]O 0.731 R32 SC N–H 0.430 1.82 16.26 0.058
MeGau C]O 0.731 Pt–NH3 N–H 0.451 1.90 10.77 0.043
NCp7-[Pt(NH3)3(7-MeGua)]
2+ B
MeGau C]O 0.679 R32 SC N–H 0.437 1.80 17.19 0.059
K34 BB C]O 0.732 MeGau N1–H 0.465 2.09 6.04 0.041
K34 BB C]O 0.732 MeGau NH2–Ha 0.436 2.21 4.44 0.020
W37 BB N 0.727 MeGau NH2–Hb 0.426 2.35 3.65 0.016
M46 SC S 0.056 Pt–NH3 N–H 0.421 2.22 17.23 0.082
M46 SC S 0.056 Pt–NH3 N–H 0.424 2.39 7.75 0.051
MeGau N3 0.641 Pt–NH3 N–H 0.449 2.38 1.70 0.013
NCp7-[Pt(NH3)3(Xan)]
2+
Xan C6]O 0.687 M46 SC N–H 0.419 2.04 6.34 0.023
Xan C6]O 0.687 W37 BB N–H 0.413 2.02 7.42 0.024
G35 BB C]O 0.762 Xan N1–H 0.483 1.91 12.41 0.040
M46 SC S 0.077 Pt–NH3 N–H 0.423 2.20 13.81 0.084
M46 SC S 0.077 Pt–NH3 N–H 0.412 2.09 16.21 0.116
Xan C2]O 0.653 R32 SC N–H 0.442 1.94 7.80 0.023
This journal is © The Royal Society of Chemistry 2017 Chem. Sci., 2017, 8, 1269–1281 | 1277
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of the series here, we hypothesized that the addition of methyl
groups to the dien ligand would increase lipophilicity, in turn
increasing the cellular accumulation. To evaluate this hypoth-
esis, we tested CCRF-CEM and Jurkat cell lines. Both cell lines
are CD4+ and HIV susceptible. The methylation of the dien did
not result in a signicant difference in the cellular accumula-
tion for platinum complexes containing 9-EtGua (1a–d), Gua
(2a–d) or Xan (a–d) (Fig. S5†). Three compounds show greater
accumulation compared to all others: 1a, 1b, and 2a. From 3 to
6 hours, a negligible increase in accumulation is seen for most
compounds, with the exception of the three compounds that see
the highest concentration of platinum per cell. The cell uptake
trends are the same for the CCRF-CEM and Jurkat cells, which
may be indicative of a similar mechanism. To rationalize the
trend upon dien methylation, the octanol–water coefficients
(log Poct/water) for compounds 1a–1d were calculated, Table S3.†
There does not appear to be a trend in the number of methyl
groups and log Poct/water or the lipophilicity and cellular accu-
mulation. Based on the cellular accumulation prole, cytotox-
icity studies were performed for compounds 1a, 1b and 2a as
well as compound 3a (to test the cytotoxicity of a xanthosine
derivative). None of the compounds exhibited signicant
cytotoxic properties with IC50 values over 100 mM in all cases,
Table S3B.† This is a desirable property, as the compounds are
ultimately designed to inhibit HIV infectivity without affecting
normal cellular function. The lack of cytotoxicity exhibited by
the compounds reported here is also favorable for anti-viral
development.
Conclusions
Thework presented highlights a systematic strategy to understand
the interaction between platinum–nucleobase compounds and
tryptophan and the tryptophan-containing NCp7 as well as some
of their basic biological properties. Modulation of an intrinsic
physicochemical property – p–p stacking interactions – can be
achieved by suitable chemical design. The use of xanthosine
Fig. 8 ONIOM(B97-D:PM6) interaction energies for platinated
nucleobases with the large NCp7 model calculated relative to the free
9-MeGua complex (A). These energies correlate well with the exper-
imental association constants Ka (Kp) (B).
Fig. 9 Effects of [Pt(dien)(9-EtGua)]2+ and [Pt(dien)(Xan)]2+ on SL2
RNA-NCp7 protein interaction. (A) [Pt(dien)(9-EtGua)]2+ incubated
with NCp7 for 30 min prior to addition of SL2. Lane 1, SL2 RNA; lane 2,
SL2 RNA + NCp7; lanes 3–6 NCp7, SL2, and 1000, 500, 250, 125 mM
[Pt(dien)(9-EtGua)]2+. (B) NCp7 was incubated with SL2 for 30 min
prior to addition of [Pt(dien)(9-EtGua)]. Lane 1, SL2 RNA; lane 2, SL2
RNA + NCp7; lanes 3–6 NCp7, SL2, and 1000, 500, 250, 125 mM
[Pt(dien)(9-EtGua)]2+ (C) [Pt(dien)(9-EtGua)]2+ incubated with NCp7
for 30 min prior to addition of SL2. Lane 1, SL2 RNA; lane 2, SL2 RNA +
NCp7; lanes 3–6 NCp7, SL2, and 1000, 500, 250, 125 mM [Pt(dien)(-
Xan)]2+. (D) NCp7 was incubated with SL2 for 30 min prior to addition
of [Pt(dien)(Xan)]2+. Lane 1, SL2 RNA; lane 2, SL2 RNA + NCp7; lanes 3–
6 NCp7, SL2, and 250, 125, 62.5, and 31.3 mM [Pt(dien)(Xan)]2+. F, free
SL-2; B, bound SL-2; *, inhibitor-SL2 aggregate.
1278 | Chem. Sci., 2017, 8, 1269–1281 This journal is © The Royal Society of Chemistry 2017
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greatly increases the association constant with the C-terminal ZF2
over the “parent” guanine-based compounds. Both DFTmodels of
the ‘small” structures and the computational approaches using
a “large” model are consistent with the experimental association
constants. The correlation of the LUMO energies of the modied
nucleobases with the DFT p-stacking energies shows that frontier
orbital energies of the individual monomers can be used as a rst
estimate of the p-stacking strength to Trp. This correlation
extends to interaction with the zinc ngers themselves where
hydrogen bonding and steric interaction can also determine the
nal recognition, as shown in more detailed atomistic modeling
of the interaction of metallated nucleobases with the large NCp7
model. In this case, the calculations conrm the interaction of the
Pt(dien) fragment with Met37 as suggested in the NMR structure
of the C-terminal NCp7 peptide with the Pt(dien)-d(TACGCC)
hexanucleotide.17 These combined theoretical and experimental
results emphasize the importance of the non-zinc-bonded resi-
dues in dictating the overall reaction and the potential for tar-
geting interactions identied through computational modeling to
enhance the promising proof-of-concept results reported in the
inhibition studies.
Both components of the NC–nucleic acid chaperone activity
have been targeted.44–46 General approaches to inhibit the
NCp7–DNA(RNA) interaction through zinc nger targeting have
used both covalent and “non-covalent” approaches to zinc
ejection.47 The results discussed here show similarities and
analogies with these broad approaches which have been used
for many organic molecules. Alkylation of nucleobase antago-
nists has been proposed as a mechanism for enhancing binding
to the essential Trp37 of NCp7.48–51 Increased p-stacking
between the positively charged methylated base and aromatic
amino acid side chains is proposed to be responsible for the
preferential recognition for an alkylated base, through lowering
of the energy of its lowest unoccupiedmolecular orbital (LUMO)
to make it a better acceptor for electron density from aromatic
side chains.50,52 In this sense the formal analogy we have made
between alkylation and platination (and metallation in general)
to guide design of coordination compounds for medicinal
applications is strengthened.
Overall, the biophysical properties displayed by the
[Pt(dien)(nucleobase)]2+ are favorable. A study of approximately
2000 small molecules from the NCI Diversity Set suggested
a possible uorescein-based pharmacore with a good correlation
between tryptophan quenching and inhibition of NC–nucleic
acid binding.53 A second high-throughput screening of small
molecules for inhibition of NC-mediated destabilization of the
stem-loop structure of cTAR DNA (a sequence complementary to
the transactivation response element) produced ve selected
hits from a total of 4800 compounds.54 The inhibitory activity of
4 of the 5 correlated with their ability to compete with the nucleic
acid for binding to NCp7.54 It is relevant that in both these
surveys the inhibitory doses (to inhibit peptide/nucleic acid)
were in the micromolar range. In the study using cTAR DNA the
apparent dissociation constants (Kd0 for inhibitor/NCp7 binding)
of two leading compounds were 7.7  106 M (designated CO7)
and 1.7  105 M (designated HO2).54 The value obtained for
[Pt(dien)(Xan)]2+ is in fact close to this latter value, further
validating the study of this class of coordination compounds as
potential inhibitors of the NCp7–RNA interaction.
Modulation of the NCp7–RNA interaction through RNA
affinity has also been examined. In this respect the affinity of
the compounds for DNA in presence of NCp7 is of high interest.
While biophysical studies would not predict a high binding
affinity for DNA in standard measurements such as Tm or EtBr
competition assays the high excess of RNA in the biophysical
studies may account for a possible “transfer” of the complex
from peptide association to polynucleotide. The details of these
reactions may depend very much on the exact experimental
conditions –while the overall hypothesis is based on one site for
the peptide (Trp) the polynucleotide will have multiple binding
sites. This transfer would be a unique approach to inhibition of
function because a priori, it is also likely to result in inhibition
of the overall interaction. The results suggest that the study of
the ternary system would be a novel approach to design of more
effective inhibitors.
This paper has emphasized the optimization of the protein–
Pt complex interactions. Nevertheless, it is of interest to briey
compare in vitro inhibition of infectivity of the prototype
[Pt(dien)(9-EtGua)]2+ with the compound SP-4-2-[PtCl(NH3)(9-
EtGua)(quinoline)]+ which displayed modest anti-HIV activity.55
For comparison, exploratory activity of [Pt(dien)(9-EtGua)]2+
against HIV-1 strains BaL, NL4-3 and 91-US001 strains in
peripheral mononuclear blood (PBMC) cells showed only
modest HIV inhibitory activity for the latter with an IC50 ¼
28.61 mM (Roger Ptak, personal communication). A number
of extra factors come into play when considering cellular
properties – amongst them the overall stability of the complex
in blood and other non-selective interactions. The concept
of “substitution-inert” is relative and while in principle,
[PtN3(nucleobase)] compounds could stack with any available
tryptophan moieties, relatively promiscuous biomolecule substi-
tution reactions of the much more substitution-reactive Pt–Cl
bond will be avoided. Optimization of the 2nd step in our
concept4,22 – slow substitution by a nucleophilic cysteinate – is
a valid approach for enhancement of specicity and differentia-
tion amongst Trpmoieties where only those in proximity to strong
nucleophiles would enhance eventual nucleobase displacement.
In summary the results presented show from rst principles the
systematic modulation of a fundamental biophysical property
through the advantage of considering hitherto relatively under-
studied non-covalent interactions – more characteristic of the
biodisciplines – compared to covalent biomolecule interactions,
generally considered as belonging to the eld of chemistry.
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